Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 39
Filter
1.
J Med Ultrasound ; 30(1): 62-64, 2022.
Article in English | MEDLINE | ID: mdl-35465595

ABSTRACT

We report a rare case of midgut malrotation and volvulus with "whirlpool sign" in a new-born infant. The "whirlpool sign" is an imaging characteristic of midgut volvulus and has a high predicting value for volvulus. Malrotation or malrotation with volvulus can be effectively diagnosed based on these characteristics. Ultrasound diagnosis has the advantage of no radiation exposure. Color Doppler documenting the reversal or aberrant superior mesenteric vein/superior mesenteric artery axis is not only predictive but also diagnostic of malrotation of gut. The rapid and accurate diagnosis of volvulus by ultrasound helps to establish the diagnosis of malrotation in time and thus allows for urgent surgical intervention to avoid bowel necrosis.

2.
J Viral Hepat ; 29(2): 107-114, 2022 02.
Article in English | MEDLINE | ID: mdl-34724288

ABSTRACT

Tenofovir disoproxil fumarate (TDF) is the preferred treatment to prevent mother-to-infant transmission in highly viremic HBV-infected women. Data on hepatitis B surface antigen (HBsAg) levels in pregnant women are lacking. We aimed to investigate prepartum and postpartum HBsAg kinetics and its correlation with HBV DNA in pregnant women. HBV-infected mothers with HBV DNA ≥7.5 log10  IU/ml were tested for HBsAg and HBV DNA from baseline to 6 months postpartum. Of the 186 pregnant women with comparable baseline HBsAg and HBV DNA, 101 received TDF from the third trimester until 1 month postpartum. At delivery, TDF group had mildly lower HBsAg (4.32 ± 0.47 vs. 4.54 ± 0.35 log10  IU/ml, p = .0004) and markedly lower HBV DNA (4.26 ± 0.97 vs. 8.11 ± 0.70 log10  IU/ml, p < .0001) than the control group. In the TDF group, mean reduction of HBsAg and HBV DNA from baseline to delivery were 0.22 ± 0.38 and 3.96 ± 0.93 log10  IU/ml. HBsAg reduction had a positive correlation (r = .309; p = .0017) with HBV DNA reduction, and was predictive of HBV DNA reduction ≥3 log10  IU/ml (area under the receiver operating characteristic curve, 0.67; 95% confidence interval, 0.50-0.82). At 6 months postpartum, TDF and control group had comparable HBsAg and HBV DNA. In conclusion, HBsAg decreased slightly at delivery in pregnant women receiving TDF. For monitoring the effect of antiviral therapy during pregnancy, HBV DNA is a better marker than HBsAg. Our data provided valuable information regarding monitoring HBV-infected pregnant women using antiviral therapy.


Subject(s)
Hepatitis B, Chronic , Hepatitis B , Pregnancy Complications, Infectious , Antiviral Agents/therapeutic use , DNA, Viral , Female , Hepatitis B/drug therapy , Hepatitis B/prevention & control , Hepatitis B Surface Antigens , Hepatitis B virus/genetics , Hepatitis B, Chronic/drug therapy , Humans , Infant , Infectious Disease Transmission, Vertical/prevention & control , Kinetics , Pregnancy , Pregnancy Complications, Infectious/drug therapy , Pregnant Women , Tenofovir/therapeutic use , Viral Load
3.
Clin Gastroenterol Hepatol ; 19(7): 1494-1496, 2021 07.
Article in English | MEDLINE | ID: mdl-32712392

ABSTRACT

Tenofovir disoproxil fumurate (TDF) therapy during late pregnancy in highly viremic mothers can reduce residual overt hepatitis B virus (HBV) infections of their infants that occur despite immunoprophylaxis.1,2 Occult HBV infection (OBI) has been defined as the presence of HBV DNA in liver or sera in subjects seronegative for hepatitis B surface antigen (HBsAg).3 OBI has been found in varying proportions of immunized infants born to HBsAg-positive mothers.4-6 We aimed to investigate the impact of maternal TDF therapy during pregnancy on vertically acquired OBI.


Subject(s)
Hepatitis B virus , Hepatitis B , DNA, Viral , Female , Hepatitis B/prevention & control , Hepatitis B Surface Antigens , Hepatitis B virus/genetics , Humans , Infant , Infectious Disease Transmission, Vertical/prevention & control , Mothers , Pregnancy , Tenofovir/therapeutic use
4.
J Med Ultrasound ; 28(3): 135-137, 2020.
Article in English | MEDLINE | ID: mdl-33282655
5.
Medicine (Baltimore) ; 99(5): e18884, 2020 Jan.
Article in English | MEDLINE | ID: mdl-32000391

ABSTRACT

INTRODUCTION: Urachal cyst is an exceptionally rare disease in children caused by the incomplete obliteration of the urachal remnant. Urachal cysts seldom cause symptoms unless a secondary infection occurs. The symptoms of an infected urachal cyst are nonspecific and may be similar to acute appendicitis or other acute abdominal conditions. However, complications attributable to a delayed diagnosis can endanger the life of a patient. PATIENT CONCERNS: A 5-year-old boy presented with a 3-day history of severe intermittent lower abdominal pain. DIAGNOSIS: Infected urachal cyst. INTERVENTIONS: The patient was treated with surgical resection of the urachus, followed by intravenous antibiotics during the hospitalization. OUTCOMES: The patient was discharged without incident 7 days after the operation. With his follow-up in our out-patient department, he recovered well without any sequelae in the 6 months post-surgery. CONCLUSION: We suggested using the abdominal echo scan to differentiate the urachal cyst because of its high sensitivity and nonradioactive characteristic, and computed tomography is a typical diagnostic tool for urachal cysts. The mainstream management of an infected urachal cyst remains surgical excision. Complete excision of urachal cysts is relatively easy in a pediatric patient and the risk of subsequent infection is low; however, patients tend to have a low, although possible, risk of potential malignant transformation over their lifetimes.


Subject(s)
Abdomen, Acute/etiology , Urachal Cyst/diagnostic imaging , Abdomen, Acute/diagnostic imaging , Child, Preschool , Humans , Male , Urachal Cyst/complications , Urachal Cyst/pathology , Urachal Cyst/surgery , Urachus/pathology
6.
J Med Ultrasound ; 28(4): 260-263, 2020.
Article in English | MEDLINE | ID: mdl-33659169

ABSTRACT

Gallstone is a rare disease in children. It might cause complications such as cholecystitis, cholangitis, and gallstone pancreatitis due to obstruction of biliary duct or secondary infection. We report a case of a 1-year, 7-month-old boy with incidental finding of gallbladder stone, who received ceftriaxone treatment after diagnosing with Salmonella enterocolitis. Herein, we review the incidence, etiology, risk factors, and management of ceftriaxone-related gallstones in children. In conclusion, these patients are suggested to receive expectant management with close follow-up instead of surgical intervention.

7.
J Med Ultrasound ; 28(4): 256-259, 2020.
Article in English | MEDLINE | ID: mdl-33659168

ABSTRACT

We report a pediatric case of Type 1C choledochal cyst presented as acute biliary colic pain. Choledochal cyst is an abnormal expansion of the biliary tract. The Type 1 choledochal cyst is the cystic dilation of the common bile duct. The Type Ic choledochal cyst is the fusiform dilatation of the common bile duct with an anomalous pancreaticobiliary junction. Patients with choledochal cysts may have the formation of cholelithiasis due to chronic biliary stagnation and repeated inflammation. Cholelithiasis may fall into the common bile duct to cause biliary colic. Abdominal sonography can be used as a preliminary examination.

8.
Medicine (Baltimore) ; 98(51): e18294, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31860977

ABSTRACT

RATIONALE: Intussusception, a common cause of intestinal obstruction in children, typically requires medical reduction. Here, we describe the case of a pair of twins who had simultaneous intussusception and were positive for fecal adenovirus-strongly indicating that adenovirus infection may be a main cause of the intussusception. PATIENT CONCERNS: Two 1-year-old twin girls were brought to Cathay General Hospital one after another on the same day. Both presented with intermittent abdominal pain, abdominal distension, diarrhea, and loss of appetite. DIAGNOSES: Their laboratory data were adenovirus positivity in rectal swab culture. Intussusception was diagnosed through a lower gastrointestinal series. INTERVENTIONS: The twins were treated with reduction for intussusception. OUTCOMES: Both patients recovered well, without recurrence. LESSONS: Most cases of intussusception are idiopathic. However, some potential risk factors-as strongly suggested by the current cases-are genetic factors and adenovirus infection.


Subject(s)
Adenovirus Infections, Human/complications , Diseases in Twins/virology , Ileal Diseases/etiology , Intussusception/etiology , Female , Humans , Ileal Diseases/diagnostic imaging , Ileal Diseases/virology , Infant , Intussusception/diagnostic imaging , Intussusception/virology , Radiography, Abdominal , Twins, Monozygotic
10.
Aliment Pharmacol Ther ; 50(3): 306-316, 2019 08.
Article in English | MEDLINE | ID: mdl-31271463

ABSTRACT

BACKGROUND: Maternal anti-viral treatment prevents mother-to-infant transmission of hepatitis B virus (HBV), but the role of neonatal viremia on subsequent HBV infection is not clear. AIMS: To investigate the effect of maternal anti-viral treatment on neonatal serum HBV DNA and hepatitis B surface antigen (HBsAg) in infants born to highly viremic mothers and the roles of neonatal markers in predicting chronic HBV infection in children. METHODS: Serum HBV DNA and HBsAg were tested in children. Of the 201 pregnant mothers, 110 received tenofovir during the third trimester. Chronic infection in children was defined by HBsAg seropositivity at 6 or 12 months lasting more than 6 months. RESULTS: The maternal HBV viral loads from baseline to delivery were 8.25 ± 0.48 to 4.29 ± 0.98 log10  IU/mL; and 8.29 ± 0.49 to 8.12 ± 0.68 log10  IU/mL in the tenofovir and control group respectively. Of the 208 children, those in the tenofovir group had a lower rate of neonatal HBV DNA seropositivity at birth (5.22% vs 30.11%, P < 0.0001) and HBsAg seropositivity at 6 months (1.74% vs 11.83%, P = 0.003) and 12 months (1.74% vs 10.75%, P = 0.007). In a first multivariate analysis, maternal HBV DNA level at delivery (odds ratio = 1.70, P = 0.0172) and neonatal HBsAg positivity (odds ratio = 19.37, P < 0.0001) were significantly associated with children's chronic HBV infection. In a second model, neonatal HBV DNA positivity was a strong independent influence variable (odds ratio = 61.89, P = 0.0002). CONCLUSIONS: Maternal tenofovir therapy decreased maternal viral load and neonatal viremia. Positive neonatal HBV DNA was highly correlated with chronic HBV infection in children. Clinical Trial Identifier: NCT01312012.


Subject(s)
Hepatitis B, Chronic/drug therapy , Hepatitis B, Chronic/prevention & control , Hepatitis B, Chronic/transmission , Infectious Disease Transmission, Vertical/prevention & control , Pregnancy Complications, Infectious/drug therapy , Tenofovir/therapeutic use , Adult , Antiviral Agents/therapeutic use , Child , DNA, Viral/blood , Female , Hepatitis B/drug therapy , Hepatitis B Surface Antigens/blood , Hepatitis B e Antigens/blood , Hepatitis B virus/genetics , Hepatitis B, Chronic/diagnosis , Herpesvirus 1, Cercopithecine/genetics , Humans , Infant , Infant, Newborn , Infectious Disease Transmission, Vertical/statistics & numerical data , Male , Mothers , Pregnancy , Pregnancy Complications, Infectious/diagnosis , Prognosis , Viral Load/drug effects , Viremia/congenital , Viremia/diagnosis , Viremia/drug therapy , Viremia/transmission , Young Adult
11.
Am J Dermatopathol ; 40(10): 767-771, 2018 Oct.
Article in English | MEDLINE | ID: mdl-29697421

ABSTRACT

Scrub typhus is becoming a clinically important cause of acute undifferentiated febrile illness in Taiwan. The incubation period is between 6 and 21 days after exposure. It is transmitted by chiggers (larva of trombiculid mite) in long grasses and in dirt-floor homes, with infection characterized by a flu-like illness of fever, headache, and myalgia lasting approximately 1 week. It has various systemic manifestations, including GI symptoms. In some, the illness progresses to multiorgan dysfunction syndrome and death. We report on a 13-year-old boy who lived in Taipei City and who had initially tentative diagnosis of acute pyrexia of unknown origin with high fever up to 40.3°C for 1 week, but later had thrombocytopenia and diffuse abdominal pain with peritoneal sign suspected acute appendicitis. During the clinical course, septic shock and disseminated intravascular coagulopathy (DIC) were noted. There were skin rash in his trunk and extremities and an eschar with black crust surrounded by a scaling erythematous rim on his right buttock. In addition, we got the information of his travel history in Green Island and Orchid Island for 10 days.With the correct antibiotics, vancomycin, meropenem, and doxycycline, the patient was getting better and corresponding with high level of granulysin and tumor necrosis factor-alpha. The diagnosis of scrub typhus was confirmed by the biopsy of eschar and high quantitative real-time polymerase chain reaction values of Orientia tsutsugamushi (16sRNA and 56 kDa) tested by Centers for Disease Control and Prevention, Taiwan. Histopathological findings of the eschar revealed the leukocytoclastic vasculitis, crust and thrombus formation with many gram-negative microorganisms, O. tsutsugamushi demonstrated by 47 kDa monoclonal antibody immunohistochemical stain and electromicroscopy. OUTCOMES: After the careful selection of appropriate antibiotics including meropenem, vancomycin, and doxycycline, he recovered and was subsequently discharged 7 days after admission. LESSON SUBSECTIONS: This case highlights that scrub typhus infection can mimic acute abdomen and septic shock with DIC. This rare presentation of acute abdomen and septic shock with thrombocytopenia and DIC caused by scrub typhus should remind physicians to be alert to the possibility of acute abdomen and febrile illness resulting from scrub typhus.


Subject(s)
Abdomen, Acute/microbiology , Antigens, Differentiation, T-Lymphocyte/blood , Scrub Typhus/microbiology , Shock, Septic/microbiology , Vasculitis, Leukocytoclastic, Cutaneous/microbiology , Abdomen, Acute/blood , Abdomen, Acute/diagnosis , Abdomen, Acute/drug therapy , Adolescent , Anti-Bacterial Agents/therapeutic use , Biomarkers/blood , Biopsy , Diagnosis, Differential , Disseminated Intravascular Coagulation/microbiology , Humans , Immunohistochemistry , Male , Predictive Value of Tests , Scrub Typhus/blood , Scrub Typhus/diagnosis , Scrub Typhus/drug therapy , Shock, Septic/blood , Shock, Septic/diagnosis , Shock, Septic/drug therapy , Thrombocytopenia/microbiology , Treatment Outcome , Tumor Necrosis Factor-alpha/blood , Vasculitis, Leukocytoclastic, Cutaneous/blood , Vasculitis, Leukocytoclastic, Cutaneous/diagnosis , Vasculitis, Leukocytoclastic, Cutaneous/drug therapy
12.
Pediatr Neonatol ; 59(5): 507-514, 2018 10.
Article in English | MEDLINE | ID: mdl-29422246

ABSTRACT

BACKGROUND: The Identification and Management of Feeding Difficulties (IMFeD™) tool was introduced in 2011 for management of children with feeding difficulties and has been used in various countries around the world. This study aimed to assess its acceptance and effectiveness in clinical practice in Taiwan. METHODS: This was a prospective, observational, multicenter study where subjects were followed over 3 months. Outpatients identified as picky eaters, having poor appetite, poor weight gain, or weight loss were enrolled. The acceptance and effectiveness of IMFeD tool were evaluated by caregivers and pediatricians. RESULTS: Among 423 children who completed the study (235 boys, 188 girls; 78.8% aged <5 years, 21.3% aged 6-10 years), the most common feeding difficulties were poor appetite in a fundamentally vigorous child (85.3%) and highly selective intake (70.2%). Mean percentiles for height and weight were 34.6 ± 25.3 and 20.3 ± 21.3 at enrolment, and increased by 5.4 and 5.9 (p < 0.0001) at the last visit, respectively. Most caregivers (86.5%) thought that the IMFeD tool helped them to understand and better identify picky eating behaviors. Pediatricians reported that the IMFeD tool was effective in 99.3% of patients for managing picky eaters in clinical practice. CONCLUSIONS: The IMFeD tool was effective in addressing differences in needs according to type of feeding difficulty by providing a systematic approach to manage feeding difficulty in Taiwanese children. It is applicable to the clinical practice and well-accepted by pediatricians and caregivers.


Subject(s)
Child Behavior Disorders/therapy , Feeding and Eating Disorders/therapy , Caregivers , Child , Child Behavior Disorders/diagnosis , Child, Preschool , Feeding and Eating Disorders/diagnosis , Female , Humans , Infant , Male , Prospective Studies
13.
Medicine (Baltimore) ; 96(52): e9434, 2017 Dec.
Article in English | MEDLINE | ID: mdl-29384922

ABSTRACT

RATIONALE: Sigmoid volvulus (SV) is an exceptionally rare but potentially life-threatening condition in children. CHIEF COMPLAINT: Abdominal distention for 1 week. DIAGNOSES: Sigmoid volvulus. PATIENT CONCERNS: We present a case of a 12-year-old boy with mechanical ileus who was finally confirmed to have SV with the combination of abdominal plain film, sonography, and computed tomography (CT) with the finding of mesenteric artery rotation. INTERVENTIONS: Because bowel obstruction was suspected, abdominal plain film, sonography, and CT were performed. The abdominal CT demonstrated whirlpool sign with torsion of the sigmoid vessels. In addition, lower gastrointestinal filling study showed that the contrast medium could only reach the upper descending colon. Therefore, he received laparotomy with mesosigmoidoplasty for detorsion of the sigmoid. OUTCOMES: The postoperative recovery was smooth under empirical antibiotic treatment with cefazolin. A follow-up lower gastrointestinal series on the seventh day of admission showed no obstruction compared with the previous series. He was finally discharged in a stable condition 8 days after admission. LESSONS: SV is a congenital anomaly and an uncommon diagnosis in children. Nevertheless, case series and case reports of SV are becoming more prevalent in the literature. Failure to recognize SV may result in life-threatening complications such as sigmoid gangrene/perforation, peritonitis, sepsis, and death. Thus, if the children have persistent and recurrent abdominal distention, abdominal pain, and vomiting, physicians should consider SV as a "do not miss diagnosis" in the differential diagnosis.


Subject(s)
Intestinal Volvulus/diagnostic imaging , Sigmoid Diseases/diagnostic imaging , Child , Humans , Intestinal Volvulus/complications , Intestinal Volvulus/surgery , Male , Sigmoid Diseases/complications , Sigmoid Diseases/surgery , Tomography, X-Ray Computed
14.
Hepatology ; 64(5): 1451-1461, 2016 11.
Article in English | MEDLINE | ID: mdl-27044007

ABSTRACT

Despite immunoprophylaxis, hepatitis B virus (HBV) transmission in highly viremic mothers remains a global health issue. Using quantitative maternal surface antigen (HBsAg) to predict HBV infection in infants has not been investigated. We enrolled 526 mother-infant pairs with positive maternal HBsAg under current immunoprophylaxis. Maternal viral load and quantitative HBsAg were measured in the peripartum period. Infant HBsAg seropositivity for more than 6 months was defined as chronic infection. Rates of chronic infection in infants at various maternal HBsAg levels were estimated using a multivariate logistic regression model. Results showed that maternal HBsAg was positively correlated with maternal viral load (r = 0.69; P < 0.001) and accurately predicted maternal viral load above 6, 7, and 8 log10 IU/mL with an area under the receiver operating characteristic curve (AUC) of 0.97, 0.98, and 0.95. Nineteen infants were chronically infected. After adjustment for the other risk factor, maternal HBsAg level was significantly associated with risk of infection (adjusted odds ratio for each log10 IU/mL increase, 15.02; 95% confidence interval [CI], 3.89-57.94; P < 0.001). The AUC for predicting infection by quantitative maternal HBsAg was comparable to that by maternal viral load (0.89 vs. 0.87; P = 0.459). Estimated rates of infection at maternal HBsAg levels of 4, 4.5, and 5 log10 IU/mL were 2.4% (95% CI, 0.1-4.6; P = 0.04), 8.6% (95% CI, 4.5-12.7; P < 0.001), and 26.4% (95% CI, 12.6-40.2; P < 0.001). CONCLUSION: Quantitative maternal HBsAg predicts infection in infants as well as maternal viral load does. Antiviral therapy may be considered in pregnant women with an HBsAg level above 4-4.5 log10 IU/mL to interrupt mother-to-infant transmission. (Hepatology 2016;64:1451-1461).


Subject(s)
Hepatitis B Surface Antigens/blood , Hepatitis B, Chronic/transmission , Infectious Disease Transmission, Vertical , Adult , Female , Hepatitis B, Chronic/epidemiology , Humans , Infant , Infant, Newborn , Infectious Disease Transmission, Vertical/statistics & numerical data , Male , Predictive Value of Tests , Pregnancy , Viral Load
15.
BMC Infect Dis ; 15: 240, 2015 Jun 23.
Article in English | MEDLINE | ID: mdl-26100919

ABSTRACT

BACKGROUND: Prior to the introduction of rotavirus vaccines, rotavirus was the leading cause of severe gastroenteritis in infants and young children, and it continues to be the leading cause in countries without vaccination programs. Rotavirus gastroenteritis results in substantial economic burden and has a pronounced effect on the family of those who are ill. Both in Taiwan and in Vietnam, rotavirus illness is viewed as a priority disease. This study assessed, in Taiwan and Vietnam, the impact of rotavirus gastroenteritis on the family among a group of parents whose children had recently been hospitalized for this illness. METHODS: In the first half of 2013, parents of children who had been hospitalized due to rotavirus infection were recruited from hospitals in Taiwan (n = 12) and Vietnam (n = 22), and participated in focus group sessions or in-depth ethnographic interviews. RESULTS: In both countries, the results point to a substantial burden on the parents concerning emotions and logistics of daily tasks, and to considerable disruptions of the family routine. Taiwanese parents reported satisfaction with the health care system, a great deal of effort to suppress emotions, a fair amount of knowledge about rotavirus, and little extra costs related to the illness. On the other hand, parents in Vietnam expressed concern about the emotional well-being of and the health care treatments for their children, were less knowledgeable regarding rotavirus infection, and experienced a substantial financial burden due to indirect costs that were related to accessing treatment. CONCLUSIONS: Families in Taiwan and Vietnam suffer from a considerable economic and emotional burden related to rotavirus gastroenteritis. One way to substantially reduce this burden is to provide universal and affordable rotavirus vaccination to susceptible children, especially since cost-effectiveness studies have demonstrated that universal vaccination would be safe and efficacious against severe rotavirus gastroenteritis in these countries.


Subject(s)
Cost of Illness , Family Health , Gastroenteritis/psychology , Health Knowledge, Attitudes, Practice , Parents/psychology , Rotavirus Infections/psychology , Stress, Psychological , Adult , Anthropology, Cultural , Child, Preschool , Emotions , Female , Focus Groups , Gastroenteritis/economics , Humans , Infant , Male , Qualitative Research , Rotavirus , Rotavirus Infections/economics , Taiwan , Vietnam , Young Adult
16.
Medicine (Baltimore) ; 94(20): e776, 2015 May.
Article in English | MEDLINE | ID: mdl-25997046

ABSTRACT

Severe adenovirus infection in children can manifest with acute respiratory distress syndrome (ARDS) and respiratory failure, leading to the need for prolonged mechanical support in the form of either mechanical ventilation or extracorporeal life support. Early extracorporeal membrane oxygenation (ECMO) intervention for children with ARDS should be considered if selection criteria fulfill.We report on a 9-month-old boy who had adenovirus pneumonia with rapid progression to ARDS. Real-time polymerase chain reaction tests of sputum and pleural effusion samples confirmed adenovirus serotype 7. Chest x-rays showed progressively increasing infiltrations and pleural effusions in both lung fields within 11 days. Because conventional ARDS therapies failed, we initiated ECMO with high-frequency oscillatory ventilation (HFOV) for 9 days. Chest x-rays showed gradual improvements in lung expansion.This patient was subsequently discharged after a hospital stay of 38 days. Post-ECMO and adenovirus sequelae were followed in our outpatient department.Adenovirus pneumonia in children can manifest with severe pulmonary morbidity and respiratory failure. The unique lung recruitment by HFOV can be a useful therapeutic option for severe ARDS patients when combined with sufficient lung rest provided by ECMO.


Subject(s)
Adenovirus Infections, Human/complications , Pneumonia, Viral/complications , Respiratory Distress Syndrome/etiology , Adenoviridae , Extracorporeal Membrane Oxygenation , High-Frequency Ventilation , Humans , Infant , Male , Pneumonia, Viral/diagnosis , Pneumonia, Viral/diagnostic imaging , Pneumonia, Viral/virology , Radiography , Real-Time Polymerase Chain Reaction , Respiratory Distress Syndrome/therapy , Respiratory Distress Syndrome/virology
17.
J Pediatr Surg ; 50(4): 581-5, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25840067

ABSTRACT

BACKGROUND/PURPOSE: The diagnostic and therapeutic benefits of a commercial water-soluble contrast agent (Gastrografin) in pediatric patients with adhesive small-bowel obstruction (ASBO) are controversial. The aim of this study was to assess the therapeutic value of Gastrografin in the management of ASBO in children after unsuccessful conservative treatment. METHODS: Medical records from patients with uncomplicated ASBO managed at Cathay General Hospital, Taipei, Taiwan between January 1996 and December 2011 were retrospectively reviewed. All children ≤18 years of age with clinical evidence of ASBO were managed conservative treatment, unless there was suspicion of strangulation. Patients who did not improve after 48 hours of conservative treatment were administered Gastrografin. RESULTS: Twenty-four patients with 33 episodes of ASBO were analyzed. Of those, there were 19 episodes of ASBO that failed to respond to the initial conservative management, and 16 (84%) responded well to Gastrografin administration thereby abrogating the need for surgical intervention. There were neither complications nor mortality that could be attributed to the use of Gastrografin. CONCLUSION: This preliminary study suggested that the use of a water-soluble contrast agent in ASBO is safe in children and useful for managing ASBO, particularly in reducing the need for surgery when conservative treatment fails. However, larger prospective studies would be needed to confirm these results.


Subject(s)
Contrast Media/therapeutic use , Diatrizoate Meglumine/therapeutic use , Intestinal Obstruction/drug therapy , Intestine, Small , Postoperative Complications/drug therapy , Administration, Oral , Adolescent , Child , Child, Preschool , Female , Humans , Infant , Infant, Newborn , Intestinal Obstruction/etiology , Male , Retrospective Studies , Tissue Adhesions/complications , Treatment Outcome
18.
Medicine (Baltimore) ; 94(6): e503, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25674743

ABSTRACT

Colon carcinoma is a rare disease in the pediatric population. Here is a report on a 17-year-old male adolescent with colon adenocarcinoma who presented with recurrent epigastric colic pain for 1 month. Diagnostic laparoscopic surgery revealed a 3.2 × 3 cm tumor at the ascending colon, with serosal involvement and peritoneal metastasis. Clinical differences of colorectal carcinoma among children and adults are reviewed and summarized.


Subject(s)
Adenocarcinoma/diagnosis , Colonic Neoplasms/diagnosis , Adolescent , Adult , Child, Preschool , Follow-Up Studies , Humans , Immunohistochemistry , Laparoscopy , Male , Radiography, Abdominal , Tomography, X-Ray Computed
19.
BMJ Open ; 4(9): e005789, 2014 Sep 15.
Article in English | MEDLINE | ID: mdl-25223569

ABSTRACT

OBJECTIVE: To assess the effectiveness of conservative treatment for adhesive small bowel obstruction (ASBO) in children. DESIGN: Systematic review of studies involved children with ASBO who received initial conservative/non-operative treatment. SETTING: The search was performed in April 2013 using PubMed (see online supplementary file 1), current contents, and the Cochrane database. PARTICIPANTS: Children with ASBO. INTERVENTIONS: Conservative treatment included nasogastric decompression, parenteral fluids and correction of electrolyte and fluid imbalance. PRIMARY OUTCOME: Treatment success. SECONDARY OUTCOMES: Length of hospital stay and the time to first feeding after hospital admission. RESULTS: 7 studies (six retrospective, one prospective), involving 8-109 patients (age: 1 month to 16 years) treated conservatively, were included in the review. The nature of conservative treatment was generally consistent between studies (nasogastric decompression, parenteral fluids and correction of electrolyte and fluid imbalance), although patients in one study also received Gastrografin. The rate of conservative treatment success ranged from 16% to 75% among the five studies, but one trial showed 0% successful rate. The hospital length of stay ranged from 3 to 6.5 days for conservative treatment (vs 10.2-13 days for operative treatment). The time to first feeding ranged from 31 to 84 h for conservative treatment. CONCLUSIONS: In conclusion, in the majority of cases, conservative treatment is an effective means of managing ASBO in children.


Subject(s)
Intestinal Obstruction/therapy , Child , Humans , Intestinal Diseases/complications , Intestinal Obstruction/etiology , Tissue Adhesions/complications
20.
J Infect Dis ; 208(12): 1968-78, 2013 Dec 15.
Article in English | MEDLINE | ID: mdl-23904296

ABSTRACT

BACKGROUND: The cutaneous manifestations of human enterovirus (HEV) infection are usually limited, such as hand-foot-mouth disease. By comparison, Stevens-Johnson syndrome (SJS) is a life-threatening severe cutaneous adverse reaction (SCAR), mainly caused by drugs. During the HEV outbreaks in 2010-2012 in Taiwan, we identified 21 patients who developed widespread blistering mucocutaneous reactions without any suspected drug causality. METHODS: We screened possible pathogen(s) for detecting human herpes virus (HHV1-HHV7), HEV, or Mycoplasma pneumoniae infections using throat swab virus cultures, real-time PCR, DNA sequencing, immunochemistry and electron microscopy analyses. RESULTS: Coxsackievirus A6 (CVA6) DNA was identified in the blistering skin lesions in 6 of 21 patients. Cytotoxic T lymphocytes and natural killer cells expressing granulysin predominantly infiltrated into the skin lesions, sharing the histopathological features with SJS. Intact CVA6 viral particles were identified in the blister fluids and skin lesions by electron microscopy. The phylogenetic analysis of the viral genome showed the CVA6 DNA sequence sharing higher similarity (97.6%-98.1%) to CVA6 strains reported from Finland at 2008. CONCLUSIONS: This study identifies a new variant of CVA6 as the causative agent for severe mucocutaneous blistering reactions mimicking SCAR. An awareness of this unusual presentation of HEV infection is needed in the epidemic area.


Subject(s)
Blister/virology , Enterovirus/isolation & purification , Hand, Foot and Mouth Disease/virology , Antigens, Differentiation, T-Lymphocyte/analysis , Antigens, Differentiation, T-Lymphocyte/chemistry , Biopsy , Blister/pathology , Body Fluids/chemistry , Body Fluids/virology , Child , Child, Preschool , DNA, Viral/genetics , DNA, Viral/isolation & purification , Enterovirus/classification , Enterovirus/genetics , Female , Hand, Foot and Mouth Disease/pathology , Humans , Killer Cells, Natural , Male , Phylogeny , Skin/chemistry , Skin/pathology , Skin/virology , T-Lymphocytes, Cytotoxic , Virion/genetics , Virion/isolation & purification
SELECTION OF CITATIONS
SEARCH DETAIL
...